Chao Zou
About Chao Zou
Chao Zou is the Associate Director of World Wide Pricing Strategy Cell Therapy at Bristol Myers Squibb, with extensive experience in global market access and pricing strategies for cell therapies.
Title
Chao Zou is the Associate Director focused on World Wide Pricing Strategy for Cell Therapy at Bristol Myers Squibb, based in Boudry, Neuchâtel, Switzerland.
Current Position at Bristol Myers Squibb
Chao Zou currently serves as the Associate Director of World Wide Pricing Strategy Cell Therapy at Bristol Myers Squibb. In this role, he is responsible for leading the pricing strategy for cell therapy products on a global scale. His work involves collaborating with cross-functional teams to optimize launch sequences and ensure effective market access for novel cell therapies, including Breyanzi, a CAR-T cell therapy product.
Previous Roles in the Pharmaceutical Industry
Chao Zou has held several significant roles in the pharmaceutical industry, specializing in market access and pricing strategies. He was Senior Manager at Celgene, focusing on CAR-T World Wide Value, Access, and Pricing. Before this, he worked as Manager of Global Market Access and Pricing at Actelion, and held a position in Pricing and Market Access at Novartis for seven years. His responsibilities in these roles included developing pricing strategies for innovative therapies and enhancing market access globally.
Education and Expertise
Chao Zou has an extensive educational background in biochemistry and biochemical engineering. He earned a Bachelor’s Degree in Biochemical Engineering from Beijing University of Chemical Technology and a Master's Degree from Tianjin University. He pursued his Ph.D. in Medical Biochemistry and Biophysics at Umeå University and another Ph.D. in Biochemistry from the University of Zurich. Additionally, he obtained a Master of Business Administration (MBA) from the University of Applied Sciences and Arts Northwestern Switzerland FHNW. His academic achievements provide a robust foundation for his work in pharmaceutical pricing and market access.
Career in Academia and Industry
Chao Zou has experience in both academic and industry settings. He worked as a Postdoctoral Fellow at Stanford University's School of Medicine, furthering his research in the field of biochemistry. Transitioning to the pharmaceutical industry, he has spent over a decade in various strategic roles at major companies, including Novartis, Actelion, and Celgene. His industry experience is marked by a consistent focus on pricing strategies and market access for innovative cell therapies.